Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 4/20 | 0.36 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13815519 | 0.81 | HTR2A (0.35) | CHRNB4CHRNA3HTR2ASLC6A2SLC6A3 | |
| SCHEMBL1201800 | 0.81 | HTR2A (0.35) | CHRNB4CHRNA3HTR2ASLC6A2SLC6A3 | |
| SCHEMBL5380020 | 0.78 | KDM4E (0.35) | KDM1AMEN1KMT2A | |
| SCHEMBL2561353 | 0.71 | SMN1; SMN2 (0.42) | HTR2AMEN1KMT2A | |
| SCHEMBL11738033 | 0.71 | CHRNB2 (0.46) | HTR2AMEN1KMT2A | |
| SCHEMBL4689201 | 0.71 | — | — | |
| SCHEMBL4404195 | 0.71 | CHRNB2 (0.46) | KDM1AKDM1B | |
| SCHEMBL4406720 | 0.69 | CHRNB2 (0.47) | CHRNB4CHRNA3KDM1AKDM1BHTR2A | |
| SCHEMBL11530896 | 0.69 | CHRNB2 (0.47) | HTR2AKMT2ASLC6A2SLC6A3 | |
| SCHEMBL7117273 | 0.69 | ALDH1A1 (0.40) | KDM1ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4114508-B1 | A SYSTEM AND METHOD FOR RELEASING A SPECIES | OBOE IPR AB (SE) | 2025-09-17 | — | — | EP | claimed |
| WO-2025070288-A1 | RESIN COMPOSITION, MOLDED BODY, AND OPTICAL COMPONENT | 三井化学株式会社 | 2025-04-03 | — | — | WO | claimed |
| US-12240930-B2 | Cyclic olefin-based copolymer, cyclic olefin-based copolymer composition, molded article, and medical container | MITSUI CHEMICALS, INC. (JP) | 2025-03-04 | — | — | US | claimed |
| US-12209147-B2 | Cyclic olefin-based resin composition, molded product, and optical component | MITSUI CHEMICALS, INC. (JP) | 2025-01-28 | — | — | US | claimed |
| WO-2024203631-A1 | PREPARATION IN CONTAINER, AND PACKAGING | 三井化学株式会社 | 2024-10-03 | — | — | WO | claimed |
| US-11732075-B2 | Cyclic olefin-based copolymer, cyclic olefin-based copolymer composition, molded article, and medical container | MITSUI CHEMICALS, INC. (JP) | 2023-08-22 | — | — | US | claimed |
| CN-113906097-B | Cyclic olefin resin composition, molded body, and optical member | 三井化学株式会社 | 2023-07-18 | — | — | CN | claimed |
| US-20230159684-A1 | CYCLIC OLEFIN-BASED COPOLYMER, CYCLIC OLEFIN-BASED COPOLYMER COMPOSITION, MOLDED ARTICLE, AND MEDICAL CONTAINER | MITSUI CHEMICALS, INC. (JP) | 2023-05-25 | — | — | US | claimed |
| CN-111406079-B | Cycloolefin copolymer, cycloolefin copolymer composition, molded article, and medical container | 三井化学株式会社 | 2023-04-04 | — | — | CN | claimed |
| US-20230076160-A1 | A SYSTEM AND METHOD FOR RELEASING A SPECIES | OBOE IPR AB (SE) | 2023-03-09 | — | — | US | claimed |
| CN-111406079-A | Cycloolefin copolymer, cycloolefin copolymer composition, molded article, and medical container | 三井化学株式会社 | 2020-07-10 | — | — | CN | claimed |
| WO-2020137709-A1 | CYCLIC OLEFIN COPOLYMER FOR OPTICAL MEMBER, CYCLIC OLEFIN COPOLYMER COMPOSITION FOR OPTICAL MEMBER, AND MOLDED ARTICLE | 三井化学株式会社 | 2020-07-02 | — | — | WO | claimed |
| WO-2020137710-A1 | CYCLO-OLEFIN COPOLYMER FOR MEDICAL DEVICES, CYCLO-OLEFIN COPOLYMER COMPOSITION FOR MEDICAL DEVICES, AND MOLDED BODY | 三井化学株式会社 | 2020-07-02 | — | — | WO | claimed |
| US-20190292389-A1 | BISMALEIMIDE-BASED SOLUTION FOR INKJET INK FOR THREE DIMENSIONAL PRINTING | SOREQ NUCLEAR RESEARCH CENTER (IL) | 2019-09-26 | — | — | US | claimed |
| CN-103570502-A | Preparation method for varenicline intermediate | SHANGHAI SYNCORES TECHNOLOGIES INC | 2014-02-12 | — | — | CN | claimed |
| EP-2204369-A1 | Process for preparing varenicline and intermediates for use therein | Medichem, S.A. (ES) | 2010-07-07 | — | — | EP | claimed |
| US-20090318695-A1 | PROCESSES FOR THE PREPARATION OF VARENICLINE AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-12-24 | — | — | US | claimed |
| WO-2009155403-A2 | PROCESSES FOR THE PREPARATION OF VARENICLINE AND INTERMEDIATES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-12-23 | — | — | WO | claimed |
| CN-101531564-A | Method for synthesizing 1,4-dihydro-1,4-methanonaphthalene | SHANGHAI RECORD PHARMACEUTICAL | 2009-09-16 | — | — | CN | claimed |
| US-4080491-A | CATALYST CONTAINS ORGANOMETALLIC COMPOUND AND THE REACTION PRODUCT OF TUNGSTEN OR MOLYBDENUM OXIDE AND A PHOSPHOROUS HALIDE OR OXYHALIDE | SHOWA DENKO K.K. (JA) | 1978-03-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318695-A1 | PROCESSES FOR THE PREPARATION OF VARENICLINE AND INTERMEDIATES THEREOF | COMT, CYP3A7, CHRNA7 | CHRNB4 45/4885CHRNA3 32/4885KDM1A 708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.